Wall Street brokerages expect Cabot Corp (NYSE:CBT) to post $744.18 million in sales for the current fiscal quarter, according to Zacks. Four analysts have provided estimates for Cabot’s earnings. The highest sales estimate is $765.84 million and the lowest is $714.48 million. Cabot posted sales of $678.00 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 9.8%. The business is expected to announce its next quarterly earnings results after the market closes on Monday, May 7th.
On average, analysts expect that Cabot will report full-year sales of $3.00 billion for the current year, with estimates ranging from $2.93 billion to $3.10 billion. For the next financial year, analysts expect that the company will post sales of $3.12 billion per share, with estimates ranging from $3.03 billion to $3.24 billion. Zacks’ sales calculations are a mean average based on a survey of analysts that cover Cabot.
Cabot (NYSE:CBT) last announced its earnings results on Tuesday, February 6th. The specialty chemicals company reported $0.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.78 by $0.15. The firm had revenue of $720.00 million for the quarter, compared to analysts’ expectations of $653.54 million. Cabot had a net margin of 2.30% and a return on equity of 15.01%. The business’s revenue was up 17.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.84 EPS.
Institutional investors have recently bought and sold shares of the stock. Citizens Financial Group Inc RI purchased a new stake in Cabot in the 4th quarter worth about $142,000. Quadrature Capital Ltd purchased a new stake in Cabot in the 4th quarter worth about $219,000. State of Alaska Department of Revenue purchased a new stake in Cabot in the 4th quarter worth about $221,000. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Cabot by 48.4% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,663 shares of the specialty chemicals company’s stock worth $226,000 after purchasing an additional 1,194 shares during the period. Finally, Signition LP purchased a new stake in Cabot in the 4th quarter worth about $229,000. 87.18% of the stock is currently owned by institutional investors.
Shares of NYSE CBT traded up $0.12 during mid-day trading on Thursday, hitting $56.84. 316,153 shares of the company’s stock traded hands, compared to its average volume of 378,029. The company has a current ratio of 1.63, a quick ratio of 1.02 and a debt-to-equity ratio of 0.43. The stock has a market capitalization of $3,513.11, a price-to-earnings ratio of 16.15, a P/E/G ratio of 1.40 and a beta of 1.40. Cabot has a 1 year low of $50.21 and a 1 year high of $68.63.
Cabot Company Profile
Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.